Literature DB >> 21833771

A program of professional accreditation of hospital wards by the Italian Society of Internal Medicine (SIMI): self- versus peer-evaluation.

Massimo Vanoli1, Giancarlo Traisci, Alberto Franchini, Gianpiero Benetti, Pietro Serra, Maria Alice Monti.   

Abstract

The Italian Society of Internal Medicine has developed a voluntary program of professional accreditation of the medical units run by its constituency. Participation in the program, which is meant to foster staff involvement in clinical governance, includes all the medical personnel and nurses. Accreditation is awarded provided the candidate unit is able to adhere to a pre-established set of quality standards, meet a number of clinical and organizational requirements and monitor specific indicators. Self-evaluation is the first step in the program, followed by a site visit by a team of peer internists experienced in quality auditing. The program, which has involved so far 19 units, has considered a number of clinical requirements related to the three most frequent diseases in Italian internal medicine wards: chronic heart failure (CHF), exacerbation of chronic obstructive pulmonary disease (COPD) and hepatic cirrhosis with ascites (HCA). The comparison between self- and peer-evaluation witnessed less discrepancies for disease-related than for organizational requirements, the latter being met to a smaller degree by most units. In particular, concordance was higher for requirements and indicators pertaining to CHF and HCA than to COPD. This program of professional accreditation developed by the Italian Society of Internal Medicine has the potential to describe, monitor and improve clinical and organizational performances in internal medicine. It should also be seen as a contribution to implement the strategy of professional governance in hospitals.

Entities:  

Mesh:

Year:  2011        PMID: 21833771     DOI: 10.1007/s11739-011-0684-6

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN: 1828-0447            Impact factor:   3.397


  15 in total

1.  Disseminating innovations in health care.

Authors:  Donald M Berwick
Journal:  JAMA       Date:  2003-04-16       Impact factor: 56.272

2.  Management of adult patients with ascites due to cirrhosis.

Authors:  Bruce A Runyon
Journal:  Hepatology       Date:  2004-03       Impact factor: 17.425

3.  Guidelines on the management of ascites in cirrhosis.

Authors:  K P Moore; G P Aithal
Journal:  Gut       Date:  2006-10       Impact factor: 23.059

4.  A European survey of general nurses' self assessment of competence.

Authors:  David T Cowan; Jenifer Wilson-Barnett; Ian J Norman
Journal:  Nurse Educ Today       Date:  2006-11-09       Impact factor: 3.442

Review 5.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary.

Authors:  R A Pauwels; A S Buist; P M Calverley; C R Jenkins; S S Hurd
Journal:  Am J Respir Crit Care Med       Date:  2001-04       Impact factor: 21.405

6.  HFSA 2006 Comprehensive Heart Failure Practice Guideline.

Authors: 
Journal:  J Card Fail       Date:  2006-02       Impact factor: 5.712

7.  Accuracy and bias in self-perception: individual differences in self-enhancement and the role of narcissism.

Authors:  O P John; R W Robins
Journal:  J Pers Soc Psychol       Date:  1994-01

Review 8.  Accuracy of physician self-assessment compared with observed measures of competence: a systematic review.

Authors:  David A Davis; Paul E Mazmanian; Michael Fordis; R Van Harrison; Kevin E Thorpe; Laure Perrier
Journal:  JAMA       Date:  2006-09-06       Impact factor: 56.272

Review 9.  ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM).

Authors:  Kenneth Dickstein; Alain Cohen-Solal; Gerasimos Filippatos; John J V McMurray; Piotr Ponikowski; Philip Alexander Poole-Wilson; Anna Strömberg; Dirk J van Veldhuisen; Dan Atar; Arno W Hoes; Andre Keren; Alexandre Mebazaa; Markku Nieminen; Silvia Giuliana Priori; Karl Swedberg
Journal:  Eur Heart J       Date:  2008-09-17       Impact factor: 29.983

10.  Chronic obstructive pulmonary disease. National clinical guideline on management of chronic obstructive pulmonary disease in adults in primary and secondary care.

Authors: 
Journal:  Thorax       Date:  2004-02       Impact factor: 9.139

View more
  6 in total

1.  Clinical governance: many fancies, very few facts.

Authors:  Pier Mannuccio Mannucci
Journal:  Intern Emerg Med       Date:  2011-12-17       Impact factor: 3.397

2.  Determining Core Components in Accreditation of Limited Surgery Facilities in Iran.

Authors:  Nader Asgari; Somayeh Hessam; Irvan Masoudi Asl; Shaghayegh Vahdat
Journal:  Galen Med J       Date:  2020-06-25

3.  Understanding how and why audits work in improving the quality of hospital care: A systematic realist review.

Authors:  Lisanne Hut-Mossel; Kees Ahaus; Gera Welker; Rijk Gans
Journal:  PLoS One       Date:  2021-03-31       Impact factor: 3.240

4.  Accreditation of nursing clinical services: Development of an appraisal tool.

Authors:  Sarieh Poortaghi; Mahvash Salsali; Abbas Ebadi; Nima Pourgholamamiji
Journal:  Nurs Open       Date:  2020-05-27

5.  A Comparison of Three Models of Hospital Performance Assessment Using IPOCC Approach.

Authors:  Roya Malekzadeh; Ghahraman Mahmoodi; Ghasem Abedi
Journal:  Ethiop J Health Sci       Date:  2019-09

6.  Mediators of change in healthcare organisations subject to external assessment: a systematic review with narrative synthesis.

Authors:  Einar Hovlid; Geir Sverre Braut; Einar Hannisdal; Kieran Walshe; Oddbjørn Bukve; Signe Flottorp; Per Stensland; Jan C Frich
Journal:  BMJ Open       Date:  2020-08-30       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.